On Tuesday, CRISPR Therapeutics AG (NASDAQ: CRSP) opened lower -0.45% from the last session, before settling in for the closing price of $50.59. Price fluctuations for CRSP have ranged from $43.42 to $91.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 33402.13%. Company’s average yearly earnings per share was noted -178.20% at the time writing. With a float of $81.47 million, this company’s outstanding shares have now reached $85.17 million.
Considering the fact that the conglomerate employs 407 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 30.6%, operating margin of -164.86%, and the pretax margin is -117.29%.
CRISPR Therapeutics AG (CRSP) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CRISPR Therapeutics AG is 4.35%, while institutional ownership is 62.48%. The most recent insider transaction that took place on Oct 14 ’24, was worth 50,399. In this transaction General Counsel and Secretary of this company sold 1,089 shares at a rate of $46.28, taking the stock ownership to the 62,597 shares. Before that another transaction happened on Oct 14 ’24, when Company’s Chief Executive Officer sold 4,293 for $46.28, making the entire transaction worth $198,680. This insider now owns 226,540 shares in total.
CRISPR Therapeutics AG (CRSP) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -178.20% per share during the next fiscal year.
CRISPR Therapeutics AG (NASDAQ: CRSP) Trading Performance Indicators
Check out the current performance indicators for CRISPR Therapeutics AG (CRSP). In the past quarter, the stock posted a quick ratio of 15.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.23, a number that is poised to hit -1.31 in the next quarter and is forecasted to reach -5.15 in one year’s time.
Technical Analysis of CRISPR Therapeutics AG (CRSP)
Compared to the last year’s volume of 1.45 million, its volume of 1.7 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 84.10%. Additionally, its Average True Range was 2.04.
During the past 100 days, CRISPR Therapeutics AG’s (CRSP) raw stochastic average was set at 31.59%, which indicates a significant decrease from 76.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.45% in the past 14 days, which was higher than the 46.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $47.24, while its 200-day Moving Average is $58.06. Nevertheless, the first resistance level for the watch stands at $51.51 in the near term. At $52.65, the stock is likely to face the second major resistance level. The third major resistance level sits at $54.89. If the price goes on to break the first support level at $48.13, it is likely to go to the next support level at $45.89. Now, if the price goes above the second support level, the third support stands at $44.75.
CRISPR Therapeutics AG (NASDAQ: CRSP) Key Stats
There are currently 85,046K shares outstanding in the company with a market cap of 4.29 billion. Presently, the company’s annual sales total 371,210 K according to its annual income of -153,610 K. Last quarter, the company’s sales amounted to 520 K and its income totaled -126,410 K.
